The Rise of a New Eugenics
By Lloyd Lewis and Julie Reiskin,
Denver Post
| 07. 04. 2013
Eugenics was a disturbing sociopolitical movement in the early 20th century that promoted reproduction of the "fittest" and limited reproduction of the "unfit" with "inferior" genes. It took root in academia, influenced a famous Supreme Court decision, and resulted in the forced sterilization of tens of thousands of mentally ill or mentally challenged women in this country.
Adolf Hitler's embrace of eugenics would discredit the movement, but unfortunately it didn't disappear. Today, in fact, we see the rise of a new eugenics, made possible by the rapid development of bioscience and biotechnology, especially from the mapping of the human genome.
We now have researchers with the scientific know-how working with Wall Street-backed corporations to develop the new weapon in the struggle to rid the world of people with developmental disabilities: a "non-invasive prenatal test (NIPT)" that can detect a "disability" or "genetic disorder" anywhere from the fifth to ninth week of pregnancy without amniocentesis. One of the first "disorders" targeted by NIPT technologies is Down syndrome (DS). Although this test is sometimes promoted for "women at risk" for having children...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...